Back to GetFilings.com



 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

 


 

FORM 10-Q

 

ý

 

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 

 

 

 

For the Quarter Ended March 31, 2004

 

 

 

 

 

 

 

OR

 

 

 

 

 

o

 

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 

 

 

 

Commission File Number 0-11336
 
 
 

CIPRICO INC.

(Exact name of Registrant as specified in its charter)

 

DELAWARE

 

41-1749708

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification Number)

 

17400 Medina Road
Plymouth, Minnesota 55447

(Address of principal executive offices)

 

Registrant’s telephone number, including area code:  (763) 551-4000

 

Indicate by checkmark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirement for the past 90 days.  Yes  ý    No  o

 

Indicate by checkmark whether the registrant is an accelerated filer (as defined by Rule 12b-2 of the Act).  Yes  o  No  ý

 

The number of shares outstanding of the registrant’s Common Stock, $.01 par value, as of April 30, 2004 was 4,727,778 shares.

 

 



 

CIPRICO INC. AND SUBSIDIARY

 

FORM 10-Q

 

INDEX

 

 

 

Page

 

 

 

PART I

Financial Information

 

 

 

 

Item 1.

Financial Statements

 

 

 

 

 

Condensed Consolidated Balance Sheets at March 31, 2004 and September 30, 2003

3

 

 

 

 

Condensed Consolidated Statements of Operations for Three and Six-Months Ended March 31, 2004 and 2003

4

 

 

 

 

Condensed Consolidated Statements of Cash Flows for Six-Months Ended March 31, 2004 and 2003

5

 

 

 

 

Notes to Condensed Consolidated Financial Statements

6-9

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

9-13

 

 

 

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

13

 

 

 

Item 4.

Controls and Procedures

13

 

 

 

PART II

Other Information

 

 

 

 

Item 6.

Exhibits and Reports on Form 8-K

13

 

 

 

SIGNATURES

14

 

EXHIBITS

 

15-18

 

 

 

31.1

Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

31.2

Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

32.1

Certification of the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

32.2

Certification of the Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

2



 

PART I  FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

 

CIPRICO INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

(In thousands)

 

March 31,
2004

 

September 30,
2003

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

6,236

 

$

5,159

 

Marketable securities

 

13,584

 

16,766

 

Accounts receivable, less allowance

 

2,536

 

4,016

 

Inventories

 

3,190

 

3,928

 

Other current assets

 

426

 

453

 

Total current assets

 

25,972

 

30,322

 

 

 

 

 

 

 

Property and equipment, net

 

1,377

 

1,972

 

Marketable securities

 

2,110

 

 

Other assets

 

42

 

42

 

 

 

$

29,501

 

$

32,336

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

1,568

 

$

2,151

 

Accrued expenses

 

1,961

 

1,887

 

Deferred revenue

 

365

 

312

 

Total current liabilities

 

3,894

 

4,350

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

Capital stock

 

47

 

47

 

Additional paid-in capital

 

35,040

 

34,840

 

Accumulated deficit

 

(9,391

)

(6,881

)

Deferred compensation from restricted stock

 

(89

)

(20

)

Total shareholders’ equity

 

25,607

 

27,986

 

 

 

$

29,501

 

$

32,336

 

 

See accompanying notes to condensed consolidated financial statements

 

3



 

CIPRICO INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

(In thousands, except

 

Three-months Ended
March 31,

 

Six-months Ended
March 31,

 

per share amounts)

 

2004

 

2003

 

2004

 

2003

 

 

 

 

 

 

 

 

 

 

 

NET SALES

 

$

4,186

 

$

8,571

 

$

10,228

 

$

16,683

 

Cost of sales

 

2,575

 

5,469

 

6,311

 

10,631

 

 

 

 

 

 

 

 

 

 

 

GROSS PROFIT

 

1,611

 

3,102

 

3,917

 

6,052

 

 

 

 

 

 

 

 

 

 

 

OPERATING EXPENSES:

 

 

 

 

 

 

 

 

 

Research and development

 

1,494

 

1,584

 

2,881

 

3,032

 

Sales and marketing

 

1,375

 

1,698

 

2,785

 

3,376

 

General and administrative

 

476

 

606

 

977

 

1,278

 

Total operating expenses

 

3,345

 

3,888

 

6,643

 

7,686

 

 

 

 

 

 

 

 

 

 

 

LOSS FROM OPERATIONS

 

(1,734

)

(786

)

(2,726

)

(1,634

)

Other income, primarily interest

 

116

 

111

 

216

 

276

 

 

 

 

 

 

 

 

 

 

 

LOSS BEFORE INCOME TAXES

 

(1,618

)

(675

)

(2,510

)

(1,358

)

Income taxes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET LOSS

 

$

(1,618

)

$

(675

)

$

(2,510

)

$

(1,358

)

 

 

 

 

 

 

 

 

 

 

Shares used to calculate net loss per share:

 

 

 

 

 

 

 

 

 

Basic and diluted

 

4,697

 

4,658

 

4,706

 

4,685

 

 

 

 

 

 

 

 

 

 

 

NET LOSS PER SHARE:

 

 

 

 

 

 

 

 

 

Basic and diluted

 

$

(0.34

)

$

(0.14

)

$

(0.53

)

$

(0.29

)

 

See accompanying notes to condensed consolidated financial statements.

 

4



 

CIPRICO INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

 

Six-months Ended
March 31,

 

(In thousands)

 

2004

 

2003

 

 

 

 

 

 

 

Cash flows for operating activities:

 

 

 

 

 

Net loss

 

$

(2,510

)

$

(1,358

)

Depreciation and amortization

 

702

 

932

 

Changes in operating assets and liabilities

 

1,820

 

(924

)

 

 

 

 

 

 

NET CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES

 

12

 

(1,350

)

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

Equipment purchases

 

(107

)

(1,058

)

Purchases of marketable securities

 

(12,505

)

(11,088

)

Proceeds from sale or maturity of marketable securities

 

13,577

 

16,078

 

 

 

 

 

 

 

NET CASH FLOWS PROVIDED BY INVESTING ACTIVITIES

 

965

 

3,932

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

Repurchase of common stock

 

 

(622

)

Proceeds from issuance of common stock

 

100

 

99

 

 

 

 

 

 

 

NET CASH FLOWS PROVIDED BY (USED IN) FINANCING ACTIVITIES

 

100

 

(523

)

 

 

 

 

 

 

Net increase in cash and cash equivalents

 

1,077

 

2,059

 

 

 

 

 

 

 

Cash and cash equivalents at beginning of period

 

5,159

 

6,413

 

 

 

 

 

 

 

Cash and cash equivalents at end of period

 

6,236

 

8,472

 

 

 

 

 

 

 

Marketable securities, current

 

13,584

 

15,628

 

Marketable securities, long-term

 

2,110

 

 

 

 

 

 

 

 

Total cash and marketable securities

 

$

21,930

 

$

24,100

 

 

See accompanying notes to condensed consolidated financial statements.

 

5



 

CIPRICO INC. AND SUBSIDIARY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2004

(Unaudited)

 

NOTE A – BASIS OF PRESENTATION

 

The principal business activity of Ciprico Inc. and subsidiary (the Company) is the design, manufacture, and marketing of storage and system solutions for digital media applications within the broadcast and entertainment, military and government, and medical imaging markets.  The Company’s solutions combine storage, networking and computing technologies to simplify and accelerate digital media workflows. The Company markets its products worldwide through a direct sales force and various distribution channels.

 

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all necessary adjustments, consisting only of a recurring nature, and disclosures to present fairly the financial position as of March 31, 2004 and the results of operations for the three-month and six-month periods ended March 31, 2004 and 2003, and the cash flows for the six-months ended March 31, 2004 and 2003. The results of operations for the six-months ended March 31, 2004 are not necessarily indicative of the results for the full year.  These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Form 10-K filed on December 12, 2003.

 

In preparation of the Company’s consolidated financial statements, management is required to make estimates and assumptions that affect reported amounts of assets and liabilities and related revenues and expenses. Actual results could differ from the estimates used by management.

 

NOTE B – MARKETABLE SECURITIES

 

The Company has invested its excess cash in commercial paper, government agencies and other asset-backed short term investments.  These investments are classified as held-to-maturity given the Company’s intent and ability to hold the securities to maturity and are carried at amortized cost.  Investments that have maturities of less than one year have been classified as current marketable securities.

 

At March 31, 2004 and September 30, 2003, amortized cost approximates fair value of held-to-maturity investments, which consist of the following (in thousands):

 

 

 

March 31,
2004

 

September 30,
2003

 

 

 

 

 

 

 

Current marketable securities:

 

 

 

 

 

Commercial Paper

 

$

11,479

 

$

14,290

 

U.S. Government Agencies

 

 

1,502

 

Asset-backed investments

 

2,105

 

974

 

 

 

13,584

 

16,766

 

 

 

 

 

 

 

Non-current marketable securities:

 

 

 

 

 

Commercial Paper

 

2,110

 

 

 

 

2,110

 

 

 

 

 

 

 

 

 

 

$

15,694

 

$

16,766

 

 

6



 

NOTE C – INVENTORIES

 

Inventory is stated at the lower of the actual cost to purchase and/or manufacture the inventory or the current estimated market value.  Cost is determined using the first-in, first-out method. Inventory costs include outside assembly charges, allocated manufacturing overhead and direct material costs.

 

As of March 31, 2004 and September 30, 2003 inventory consisted of the following (in thousands):

 

 

 

March 31,
2004

 

September 30,
2003

 

 

 

 

 

 

 

Finished Goods

 

$

858

 

$

967

 

Work-in-Process

 

1,087

 

567

 

Raw Materials

 

1,245

 

2,394

 

 

 

$

3,190

 

$

3,928

 

 

NOTE D – WARRANTY COSTS

 

The Company provides a three-year warranty on its products.  The Company estimates future warranty claims based on historical experience and anticipated costs to be incurred.  Warranty expense is accrued at the time of sale with an additional accrual for specific items after the sale when their existence is known and amounts are determinable.

 

The following represents a reconciliation of changes in the Company’s accrued warranty as of March 31, 2004 (in thousands):

 

Balance at
September 30, 2003

 

Charged to
Costs and
Expenses

 

Deductions

 

Balance at
March 31, 2004

 

$

387

 

$

93

 

$

179

 

$

301

 

 

NOTE E – SHAREHOLDERS’ EQUITY

 

Stock Option Plan

 

The Company has a stock option plan under which officers, directors, employees and consultants have been or may be granted incentive and nonqualified stock options to purchase the Company’s common stock at fair market value on the date of grant.  The options become exercisable over varying periods and expire up to 10 years from the date of grant.  The Company applies APB Opinion 25, Accounting for Stock Issued to Employees, and related Interpretations in accounting for its plans.  No stock-based employee compensation cost is reflected in net income, as all options granted under this plan had an exercise price equal to the market value of the underlying common stock on the date of the grant.  The following table illustrates the effect on net income and earnings per share if the Company had applied the fair value recognition provisions of FASB Statement 123, Accounting for Stock-Based Compensation, to stock-based employee compensation.

 

7



 

 

 

Three-months Ended
March 31,

 

Six-months Ended
March 31,

 

 

 

2004

 

2003

 

2004

 

2003

 

 

 

 

 

 

 

 

 

 

 

Net loss, as reported

 

$

(1,618

)

$

(675

)

$

(2,510

)

$

(1,358

)

Deduct: Total stock-based employee compensation expense determined under fair value based method for awards granted, modified, or settled, net of related tax effects

 

(100

)

(107

)

(200

)

(214

)

Pro forma net loss

 

$

(1,718

)

$

(782

)

$

(2,710

)

$

(1,572

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss per share

 

 

 

 

 

 

 

 

 

Basic and Diluted – as reported

 

$

(0.34

)

$

(0.14

)

$

(0.53

)

$

(0.29

)

Basic and Diluted – pro forma

 

$

(0.37

)

$

(0.17

)

$

(0.58

)

$

(0.34

)

 

Stock Repurchase

 

The Company has a stock buyback program with authorized share repurchases under the plan of $12.0 million.  There were no repurchases of stock for the six months ended March 31, 2004.  As of March 31, 2004, 1,037,035 shares of common stock have been repurchased for approximately $7.8 million.

 

NOTE F – NET LOSS PER SHARE

 

The Company’s basic net loss per share amounts have been computed by dividing net loss by the weighted average number of outstanding common shares.  The Company’s diluted net loss per share is computed by dividing net loss by the weighted average number of outstanding common shares and common share equivalents, when dilutive.

 

For the three-month periods ended March 31, 2004 and 2003, common stock equivalents of 81,247 and 57,793 were excluded from the computation of the net loss per share since they were antidilutive, as the Company incurred net losses.  Options to purchase 609,422 and 833,238 shares of common stock with a weighted average exercise price of $7.18 and $8.46 were outstanding at March 31, 2004 and 2003, but were excluded from the computation of common share equivalents for the three-month period because they were antidilutive as the exercise prices were greater than the average market price of the Company’s stock during the period.

 

For the six-month periods ended March 31, 2004 and 2003, common stock equivalents of 77,756 and 22,336 were excluded in the computation of the net loss per share since they were antidilutive, as the Company incurred net losses.  Options to purchase 577,326 and 799,241 shares of common stock with a weighted average exercise price of $7.58 and $8.82 were outstanding at March 31, 2004 and 2003, but were excluded from the computation of common share equivalents for the six-month period because they were antidilutive as the exercise prices were greater than the average market price of the Company’s stock during the period.

 

NOTE G – SIGNIFICANT CUSTOMERS

 

Sales to significant customers as a percentage of sales for the six-month period ended March 31, are shown in the chart below.

 

 

 

2004

 

2003

 

Customer A

 

40

%

34

%

Customer B

 

10

 

9

 

Customer C

 

10

 

7

 

Customer D

 

2

 

15

 

 

 

62

%

65

%

 

8



 

NOTE H – SUBSEQUENT EVENT

 

On April 26, 2004, the Company announced the implementation of a business reorganization and a 40% workforce reduction.  In connection with these actions, the Company expects to record non-recurring charges in the third fiscal quarter totaling approximately $3.0 million.  These amounts include severance and related costs, lease abandonment costs associated with satellite offices and a portion of its manufacturing and headquarters facility, write-down of certain fixed assets and adjustments to reduce certain product inventory to market value.

 

CIPRICO INC. AND SUBSIDIARY

ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Critical Accounting Policies and Estimates

 

Note 1 of the Notes to the Consolidated Financial Statements included in the Annual Report on Form 10-K includes a summary of the significant accounting policies and methods used in the preparation of our Consolidated Financial Statements. The following is a brief discussion of the more significant accounting policies and methods used by Ciprico Inc. (“the Company, we and our”):

 

General

 

Management’s discussion and analysis of Ciprico’s financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. The most significant estimates and assumptions relate to the recoverability of receivables and inventories. Actual amounts could differ significantly from these estimates.

 

Revenue Recognition

 

We recognize revenue in accordance with SEC Staff Accounting Bulletin No. 101, “Revenue Recognition in Financial Statements”, as amended, which requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred or services rendered; (3) the fee is fixed and determinable; and (4) collectibility is reasonably assured. Products sold are generally covered by a warranty for periods up to three years. We accrue a warranty reserve within cost of sales for estimated costs to provide warranty services. We estimate the costs to service our warranty obligations based on historical experience and expectation of future conditions.  Revenue from the sale of extended warranty and maintenance agreements is deferred and recognized on a straight-line basis over the term of the related agreement.

 

Accounts Receivable

 

We perform ongoing credit evaluations of our customers and adjust credit limits based upon payment history and the customer’s current credit worthiness, as determined by our review of their current credit information. We continuously monitor collections and payments from our customers and maintain a provision for estimated credit losses based upon our historical experience and any specific customer collection issues that we have identified. While such credit losses have historically been within our expectations and the provisions established, we can not guarantee that we will continue to experience the same credit loss rates that we have in the past. Since our accounts receivable are concentrated in a relatively few number of customers, a significant change in the liquidity or financial position of any one of these customers could have a material adverse impact on the collectibility of our accounts receivable and our future operating results.

 

9



 

Inventories

 

We value our inventory at the lower of the actual cost to purchase and/or manufacture the inventory or the current estimated market value of the inventory. We regularly review inventory quantities on hand and record a provision to reduce excess and obsolete inventory to estimated market value based primarily on our estimated forecast of product demand and production requirements for the next twelve months or expected life of the representative product. A significant decrease in demand could result in an increase in the amount of excess inventory quantities on hand. If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required. Additionally, our estimates of future product demand may prove to be inaccurate, in which case we may have understated or overstated the provision required for excess and obsolete inventory. If our inventory is determined to be overvalued, we would be required to recognize such costs in our cost of goods sold at the time of such determination.

 

We make every effort to ensure the accuracy of our forecasts of future product demand, however any significant unanticipated changes in demand or technological developments could have a significant impact on the value of our inventory and our reported operating results.

 

Warranty

 

Our warranty reserve is established based on our best estimate of the amounts necessary to settle future and existing claims on products sold as of each balance sheet date. While we believe that our warranty reserve is adequate and that our estimate is appropriate, such amounts estimated to be due and payable could differ materially from what will actually transpire in the future.  To the extent we experience increased warranty claim activity or increased costs associated with servicing those claims, we would increase our warranty accrual resulting in decreased gross profit.  Similarly, if the opposite occurs and we experience better than expected results, we would decrease our warranty accrual.

 

Deferred Taxes

 

We record a valuation allowance to reduce our net deferred tax assets to the amount that is more likely than not to be realized. We recognize deferred tax assets and liabilities based on the differences between the financial statement carrying amounts and the tax bases of assets and liabilities. We regularly review the deferred tax assets for recoverability and establish a valuation allowance based on historical taxable income or loss, projected future taxable income or loss, and the expected timing of the reversals of existing temporary differences.

 

The following discussion and analysis of the financial condition and results of operations of Ciprico Inc. and its subsidiaries should be read in conjunction with the Condensed Consolidated Financial Statements and the Notes thereto, included elsewhere in this Report.

 

OVERVIEW

 

Ciprico Inc. designs, manufactures and markets storage and system solutions for digital media applications.  Our solutions combine storage, networking and computing technologies to simplify and accelerate digital media workflows. Our primary markets are broadcast and entertainment, which include applications in digital broadcast, film and video production, and military and government which include applications involving the data capture, processing and dissemination of surveillance images.  In addition, we have historically sold in other markets with high-performance storage requirements such as geosciences, digital prepress and medical imaging.

 

10



 

RESULTS OF OPERATIONS

 

Three and Six-months Ended March 31, 2004 Compared to Three and Six-months Ended March 31, 2003

 

Comparative information on sales by market for the period ended March 31, are shown in the chart below (in millions).

 

For the Three-months Ended March 31:

 

 

 

 

2004

 

2003

 

Market

 

Sales

 

% of Total

 

Sales

 

% of Total

 

Broadcast & Entertainment

 

$

1.4

 

33

%

$

6.5

 

76

%

Military & Government

 

2.7

 

64

 

2.0

 

23

 

Other

 

0.1

 

3

 

0.1

 

1

 

Total

 

$

4.2

 

100

%

$

8.6

 

100

%

 

For the Six-months Ended March 31:

 

 

 

2004

 

2003

 

Market

 

Sales

 

% of Total

 

Sales

 

% of Total

 

Broadcast & Entertainment

 

$

5.2

 

51

%

$

11.2

 

67

%

Military & Government

 

4.5

 

44

 

5.2

 

31

 

Other

 

0.5

 

5

 

0.3

 

2

 

Total

 

$

10.2

 

100

%

$

16.7

 

100

%

 

Net sales for the three-month period ended March 31, 2004 decreased 51% to $4.2 million compared to $8.6 million for the comparable period in 2003.  Net sales for the six-month period ended March 31, 2004 decreased 39% to $10.2 million compared to $16.7 million for the same period last year.

 

Sales in the Broadcast segment decreased $5.1 million or 78% and $6.0 million or 54% for the three and six-month periods ended March 31, 2004, respectively.  The decreased sales in the Broadcast segment between the periods can be attributed to lower demand from our larger OEM customers, which we believe reflects soft conditions in that sector.  In addition the effects of competitive serial ATA (SATA) products in certain applications has adversely impacted our sales volumes with our broadcast OEM customers between years.

 

Sales in the Military segment increased $700,000 or 35% for the three-month period ended March 31, 2004 compared to the prior year period.  Sales for the six-month period ended March 31, 2004 decreased $700,000 or 13% compared to the prior year period.  Sales for three-month period ended March 31, 2004 reflect approximately $700,000 of sales of our TALONä 2211 rugged and removable storage product into several new programs with new and existing customers.  Sales in the Military segment have historically fluctuated between periods due to the timing of spending on defense-related programs.  We believe the timing of design-in cycles and funding dependencies of a number of programs has adversely impacted sales activity of our newer fibre channel products such as the FibreSTORE® 2210 in this segment.  The increase in the other market for the six months ended March 31, 2004 can be principally attributed to sales of our DiMedaä product to new customers in the medical imaging and enterprise markets.

 

Our revenue growth going forward will be dependent on market acceptance of new products, expansion of products into new applications within our historical markets and new market opportunities, and success of programs that specify Ciprico products.

 

Gross profit, as a percentage of net sales, was 38.5% and 38.3% for the three and six-month periods ended March 31, 2004, compared to 36.2% and 36.3% for the same prior year periods.  This increase primarily reflects the lower mix of sales in the Broadcast segment, which has historically had lower margins and to a lesser extent impacts from expense reduction efforts in the prior year and sales of our new TALON and DiMeda products.  These impacts were offset by unfavorable overhead absorption due to overall lower volumes between years.

 

11



 

Research and development expenses were $1.5 million and $2.9 million for the three and six-month periods ended March 31, 2004, as compared to $1.6 million and $3.0 million for the same prior year periods, a decrease of $100,000 for each period, respectively. Sales and marketing expenses were $1.4 million and $2.8 million for the three and six-month periods ended March 31, 2004, compared to $1.7 million and $3.4 million for the same prior year periods, a decrease of $300,000 and $600,000, respectively.  These reductions in operating expenses are primarily the result of reduced headcount between years resulting from our restructuring efforts implemented in fiscal 2003.  For the first half of fiscal 2004, we incurred approximately $150,000 of prototype and related development costs associated with our new FibreSTORE 2212A SATA product.

 

General and administrative expenses were $476,000 and $977,000 for the three and six-month periods ended March 31, 2004, compared to $606,000 and $1.3 million for the same prior year periods, a decrease of $130,000 and $323,000, respectively.  This reduction primarily reflects reduced headcount between years, lower provision for bad debts and decreased legal and professional fees.

 

Other income increased approximately $5,000 for the three-month period and decreased $60,000 for the six-month periods ended March 31, 2004, as compared to the same prior year periods. The slight increase in the three-month period is a result of higher investment yields for the period due primarily to shift in portfolio mix. The decrease for the six-month period is due primarily to overall lower investment yields and lower cash and marketable securities balances between periods.

 

On April 26, 2004 we announced the first result of our strategic review, which included the implementation of a business reorganization and 40 percent workforce reduction.  With these changes we expect to reduce annual operating costs by approximately $3.8 million, including $3.0 million of operating expenses and $800,000 in cost of sales, beginning in the fourth fiscal quarter.  In connection with these actions, we expect to record non-recurring charges in the third fiscal quarter of approximately $3.0 million.  These amounts include severance and related costs, lease abandonment costs associated with satellite offices and a portion of our manufacturing and headquarters facility, write-down of certain fixed assets and adjustments to reduce certain product inventory to market value.

 

Given the uncertainties with timing of new product sales, it is difficult to predict any future quarterly sales levels.  We expect to incur losses for the next six months as we work new sales opportunities and release our new FibreSTORE 2212A SATA product.  We expect our use of cash during this period will closely track our operating losses and we may use up to $3 million of cash from operations during this period, exclusive of any restructuring costs.

 

LIQUIDITY AND CAPITAL RESOURCES

 

As of March 31, 2004, we had cash, cash equivalents and marketable securities totaling $21.9 million compared to $21.9 million at the end of fiscal 2003.

 

Cash flows from operating activities were $12,000 for the six-months ended March 31, 2004 compared to $1.4 million for the same period last year.  The decrease in the use of cash from operations between years primarily reflects the positive impacts from working capital changes including normal accounts receivable collections and accounts payable payments with lower sales between periods and a slight reduction in inventories of $100,000 during the quarter.  Capital expenditures of approximately $107,000 for the six-months ended March 31, 2004 primarily reflect spending related to our new product development efforts.  We anticipate that capital expenditures for fiscal 2004 will approximate $200,000 to $400,000.  There was no share repurchase activity for the six-months ended March 31, 2004.  The remaining authorization as of March 31, 2004 under our stock buyback program is $4.2 million.

 

FORWARD-LOOKING STATEMENTS

 

Certain statements in this Form 10-Q are forward-looking and are subject to various risks and uncertainties, which may cause actual results to differ from the expectations set forth in these forward-looking statements.  Such forward-looking statements, which reflect our current view of future events and financial performance, involve known and unknown risks, which include, but are not limited to, the risk factors set forth in our Form 10-K filed on December 12, 2003.  Some of these reasons include the impact on revenues and earnings of the timing of product enhancements and new product releases; market acceptance of new products; sales and distribution issues; competition; dependence on suppliers;

 

12



 

dependence on the cost of disk drives; limited backlog and the historic and recurring pattern of a disproportionate percentage of total quarterly sales occurring the last month and weeks of a quarter.  Investors should take such risks into account when making investment decisions. Shareholders and other readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. Ciprico undertakes no obligation to update publicly or revise any forward-looking statements.

 

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

The Company invests its excess cash in money market mutual funds, highly rated corporate debt securities and certain asset-backed investments.  All investments are held-to-maturity.  The market risk on such investments is minimal.  Receivables from sales to foreign customers are denominated in U.S. Dollars.  If the currencies of these countries were to fall significantly against the U.S. Dollar, there can be no assurance that such companies would be able to repay the receivables in full. Transactions at the Company’s foreign subsidiary are denoted in pounds sterling.  The Company has historically had minimal exposure to changes in foreign currency exchange rates and, as such, has not used derivative financial instruments to manage foreign currency fluctuation risk.

 

ITEM 4.  CONTROLS AND PROCEDURES

 

Ciprico management, including the Chief Executive Officer and Chief Financial Officer, have conducted an evaluation of the effectiveness of disclosure controls and procedures pursuant to Exchange Act Rule 13a-14.  Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the disclosure controls and procedures are effective in ensuring that all information required to be disclosed by the Company in reports that it files under the Exchange Act is recorded, processed, summarized and reported within the time period covered by this report.  There have been no changes in the Company’s internal controls over financial reporting that occurred during the period covered by this report that have materially affected or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

PART II - OTHER INFORMATION

 

Item 6.  Exhibits and Reports on Form 8-K

(a)

Exhibits

 

31.1

 

Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

31.2

 

Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

32.1

 

Certification of the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

32.2

 

Certification of the Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

 

(b)

 

 

Reports on Form 8-K

 

 

 

The Company filed a Current Report on Form 8-K with the Commission on April 26, 2004 with respect to the press release dated April 26, 2004 announcing the Company’s results of operations for the three and six-month periods ended March 31, 2004.

 

13



 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

CIPRICO INC.

 

 

 

 

Dated:  May 13, 2004

/s/ James W. Hansen

 

James W. Hansen,

 

Interim Chief Executive Officer

 

(Interim Chief Executive Officer)

 

 

 

 

 

 

Dated:  May 13, 2004

/s/ Thomas S. Wargolet

 

Thomas S. Wargolet, Vice President of

 

Finance/Chief Financial Officer

 

(Principal Financial and Accounting Officer)

 

14